#VisualAbstract: Posaconazole is non-inferior to voriconazole for primary treatment of invasive aspergillosis
1. Posaconazole was non-inferior to voriconazole with respect to all-cause mortality at day 42 (15% vs. 21%, respectively). 2. Incidence of ...